Akorn's long-term debt is $29K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (March 2020), AKRX shows a long-term debt of $29K. That compares with $820M in the prior-year period — down 100.0% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, AKRX's long-term debt is now $29K (was $820M) — a 100.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Akorn is outperforming or lagging.
Tracking AKRX's long-term debt over time shows whether Akorn is scaling, shrinking, or reshaping that part of the business. The current reading is $29K That compares with $820M in the prior-year period — down 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this long-term debt page, Stockcircle has Akorn's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $29K) with ownership activity and broader fundamentals.
Akorn's long-term debt is $29K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.